Clinical variation in epidermolysis bullosa: a new layer of complexity and a new opportunity for understanding wound healing

The Defense Health Agency awarded a $293,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Medical Research, Infrastructure And Health Services Fund Of The Tel Aviv Medical Center in Israel. The grant, awarded on April 1, 2025, supports a research project investigating "Clinical Variation in Epidermolysis Bullosa: A New Layer of Complexity and a New Opportunity for Understanding Wound Healing." This specialized medical research project aims to advance the understanding of a rare genetic skin condition and its implications for wound healing mechanisms, which could benefit military personnel. The grant recipient is an international, non-profit research organization with a focus on complex clinical studies involving rare medical conditions and neurological disorders. The research approach involves comprehensive methodologies such as securing IRB approvals, device acquisition, participant recruitment, data collection, and scientific analysis.